approved

Приложение 4 на ПЛС актуализация 02.10.2016

Unique identificator:  84597fd4-9e0d-47ac-b82f-571070203cd1

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2016-10-13 14:34:02
  • Created by: georgi_sivchev
  • Updated at: 2018-10-16 08:34:00
  • Updated by: migrate_data
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Poliomyelitis vaccine, (live attenuated) II-15207/12.12.2006 г. POLIO SABIN (ORAL), Oral drops, suspension, 10 doses (1 ml), -, Pack: 100 vial + dropper applicator ГлаксоСмитКлайн ЕООД, България GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium 655.2 131.04 786.24 4% 10 665.2 133.04 798.24 16% 25 690.2 138.04 828.24 КЦ-773/02.04.2009 06.05.2009 06.05.2009 Неактивен 687
Memantine 20130396 Polmatine, Film coated tablet, 10, mg, Pack: 28 Medana Pharma S.A., Полша Pharmaceutical Works POLPHARMA S.A.,Полша 47.35 9.47 56.82 4% 1.89 49.24 9.85 59.09 16% 7.58 56.82 11.36 68.18 НСР-6503/18.06.2015 04.07.2015 04.07.2015 Активен 2562
Memantine 20130396 Polmatine, Film coated tablet, 10, mg, Pack: 28 Medana Pharma S.A., Полша Pharmaceutical Works POLPHARMA S.A.,Полша 54 10.8 64.8 4% 2.16 56.16 11.23 67.39 16% 8.64 64.8 12.96 77.76 НСР-2908/05.03.2014 20.03.2014 20.03.2014 Неактивен 2562
Memantine 20130398 Polmatine, Oral solution, 5 mg/pump actuation/- 50ml, mg, Pack: 1 Medana Pharma S.A., Полша Medana Pharma SA, Полша 90.01 18 108.01 4% 3.6 93.61 18.72 112.33 16% 14.4 108.01 21.6 129.61 НСР-3029/21.03.2013 09.04.2014 09.04.2014 Активен 2611
Technetium (99mTc) pertechnetate 20150115 Poltechnet 8,0 - 175 GBq, radionuclide generator, 7,5 GBq, GBq, Pack: 1 National Centre for Nuclear Research, Полша, Полша National Centre for Nuclear Research, Полша; I.R.E. (Institut National des Radioéléments), Белгия; NTP Radioisotopes SOC Ltd., ЮАР 1157.85 231.57 1389.42 4% 10 1167.85 233.57 1401.42 16% 25 1192.85 238.57 1431.42 НСР-7353/05.11.2015. и НСР-7500/13.11.2015. (допуска се предварително изпълнение) 13.11.2015 13.11.2015 Активен 4103
Technetium (99mTc) pertechnetate 20150115 Poltechnet 8,0 - 175 GBq, radionuclide generator, 12,5 GBq, GBq, Pack: 1 National Centre for Nuclear Research, Полша, Полша National Centre for Nuclear Research, Полша; I.R.E. (Institut National des Radioéléments), Белгия; NTP Radioisotopes SOC Ltd., ЮАР 1488.39 297.68 1786.07 4% 10 1498.39 299.68 1798.07 16% 25 1523.39 304.68 1828.07 НСР-7353/05.11.2015. и НСР-7500/13.11.2015. (допуска се предварително изпълнение) 13.11.2015 13.11.2015 Активен 4104
Perindopril, Indapamide 20110360 Pontea, Film coated tablet, 4 mg/ 1,25 mg, mg, Pack: 30 Stada Arzneimittel AG, Германия STADA Arzneimittel AG, Stadastrasse 2-18, 61118 Bad Vilbel, Германия 6.2 1.24 7.44 7% 0.43 6.63 1.33 7.96 20% 1.24 7.87 1.57 9.44 промяна на обстоятелства НСР-10050/18.08.2016 НСР-6149/29.04.2015. 14.05.2015 02.10.2016 Активен 3864
Perindopril, Indapamide 20110360 Pontea, Film coated tablet, 4 mg/ 1,25 mg, mg, Pack: 30 Stada Arzneimittel AG, Германия Glenmark Pharmaceutical Ltd – UK; Glenmark Pharmaceutical sro – Czech Republic 6.2 1.24 7.44 7% 0.43 6.63 1.33 7.96 20% 1.24 7.87 1.57 9.44 НСР-6149/29.04.2015. 14.05.2015 14.05.2015 Неактивен 3864
Perindopril, Indapamide 20110359 Pontea, Film coated tablet, 2 mg/ 0,625 mg, mg, Pack: 30 Stada Arzneimittel AG, Германия STADA Arzneimittel AG, Stadastrasse 2-18, 61118 Bad Vilbel, Германия 3.64 0.73 4.37 7% 0.25 3.89 0.78 4.67 20% 0.73 4.62 0.92 5.54 промяна на обстоятелства НСР-10049/18.08.2016 НСР-2504/24.01.2014 14.02.2014 02.10.2016 Активен 2479
Perindopril, Indapamide 20110359 Pontea, Film coated tablet, 2 mg/ 0,625 mg, mg, Pack: 30 Stada Arzneimittel AG, Германия Glenmark Pharmaceutical Ltd – UK; Glenmark Pharmaceutical sro – Czech Rep. 3.64 0.73 4.37 7% 0.25 3.89 0.78 4.67 20% 0.73 4.62 0.92 5.54 НСР-2504/24.01.2014 14.02.2014 14.02.2014 Неактивен 2479
Perindopril, Indapamide 20110360 Pontea, Film coated tablet, 4 mg/ 1,25 mg, mg, Pack: 30 Stada Arzneimittel AG, Германия Glenmark Pharmaceutical Ltd – UK; Glenmark Pharmaceutical sro – Czech Rep 7.53 1.51 9.04 7% 0.53 8.06 1.61 9.67 20% 1.51 9.57 1.91 11.48 НСР-2505/24.01.2014 14.02.2014 14.02.2014 Неактивен 3864
Perindopril, Indapamide 20110360 Pontea, Film coated tablet, 4 mg/ 1,25 mg, mg, Pack: 30 Stada Arzneimittel AG, Германия Glenmark Pharmaceutical Ltd – UK; Glenmark Pharmaceutical sro – Czech Rep 7.78 1.56 9.34 7% 0.54 8.32 1.66 9.98 20% 1.56 9.88 1.98 11.86 КЦРР-1358/05.09.2012 02.10.2012 02.10.2012 Неактивен 3864
Perindopril, Indapamide 20110359 Pontea, Film coated tablet, 2 mg/ 0,625 mg, mg, Pack: 30 Stada Arzneimittel AG, Германия Glenmark Pharmaceutical Ltd – UK; Glenmark Pharmaceutical sro – Czech Rep. 4.79 0.96 5.75 7% 0.34 5.13 1.03 6.16 20% 0.96 6.09 1.22 7.31 КЦРР-1227/13.08.2012 14.09.2012 14.09.2012 Неактивен 2479
Topotecan EU/1/10/660/002 POTACTASOL, Powder for concentrate for solution for infusion, 4, mg, Pack: 1 Actavis Group PTC ehf., Исландия S.C. Sindann-Pharma S.R.L., Romania 59.4 11.88 71.28 4% 2.38 61.78 12.36 74.14 16% 9.5 71.28 14.26 85.54 НСР-3817/16.06.2014 01.07.2014 01.07.2014 Активен 2969
Topotecan EU/1/10/660/002 POTACTASOL, Powder for concentrate for solution for infusion, 4, mg, Pack: 1 Actavis Group PTC ehf., Исландия S.C. Sindann-Pharma S.R.L., Romania 153.61 30.72 184.33 4% 6.14 159.75 31.95 191.7 16% 24.58 184.33 36.87 221.2 КЦРР-2961/20.03.2013 24.04.2013 24.04.2013 Неактивен 2969
Topotecan EU/1/10/660/002 POTACTASOL, Powder for concentrate for solution for infusion, 4, mg, Pack: 1 Actavis Group PTC ehf., Исландия S.C. Sindann-Pharma S.R.L., Romania 284.24 56.85 341.09 4% 10 294.24 58.85 353.09 16% 25 319.24 63.85 383.09 КЦ-2433/06.07.2011 26.07.2011 26.07.2011 Неактивен 2969
Tuberculini purified Protein Derivative for human use 20000719 PPD Tuberculin Mammalian, Solution for injection, 5 TU/0.1 ml - 1 ml, -, Pack: x 10 флакони (10 дози) БУЛ БИО-НЦЗПБ ЕООД, България БУЛ БИО -НЦЗПБ ЕООД, София, България 66 13.2 79.2 4% 2.64 68.64 13.73 82.37 16% 10.56 79.2 15.84 95.04 НСР-9381/01.06.2016 02.07.2016 02.07.2016 Активен 15138
Tuberculini purified Protein Derivative for human use 0995/05.11.2007 г. PPD Tuberculin Mammalian, Solution for injection, 5 TU/0,1 ml, -, Pack: 1 fl. x 1 ml (10 doses) БУЛ БИО-НЦЗПБ ЕООД, България БУЛ БИО-НЦЗПБ ЕООД 35 7 42 4% 1.4 36.4 7.28 43.68 16% 5.6 42 8.4 50.4 протокол № 174/19.05.2016 КЦ-117/23.06.2008 23.07.2008 23.07.2008 Активен 66
Tuberculini purified Protein Derivative for human use 0995/05.11.2007 г. PPD Tuberculin Mammalian, Solution for injection, 5 TU/0,1 ml, -, Pack: 10 ampoules БУЛ БИО-НЦЗПБ ЕООД, България БУЛ БИО-НЦЗПБ ЕООД 35 7 42 4% 1.4 36.4 7.28 43.68 16% 5.6 42 8.4 50.4 КЦ-117/23.06.2008 23.07.2008 23.07.2008 Неактивен 66
Dabigatran etexilate EU/1/08/442/011 PRADAXA, Capsule, hard, 150, mg, Pack: 60 Boehringer Ingelheim International GmbH, Германия Boehringer Ingelheim Pharma GmbH & Co. KG, Germany 111.99 22.4 134.39 4% 4.48 116.47 23.29 139.76 16% 17.92 134.39 26.88 161.27 НСР-7654/01.12.2015. 16.12.2015 16.12.2015 Активен 2546
Dabigatran etexilate EU/1/08/442/011 PRADAXA, Capsule, hard, 150, mg, Pack: 60 Boehringer Ingelheim International GmbH, Германия Boehringer Ingelheim Pharma GmbH & Co. KG, Germany 113.83 22.77 136.6 4% 4.55 118.38 23.68 142.06 16% 18.21 136.59 27.32 163.91 НСР-2857/21.02.2014 10.03.2014 10.03.2014 Неактивен 2546
Dabigatran etexilate EU/1/08/442/011 PRADAXA, Capsule, hard, 150, mg, Pack: 60 Boehringer Ingelheim International GmbH, Германия Boehringer Ingelheim Pharma GmbH & Co. KG, Germany 117.35 23.47 140.82 4% 4.69 122.04 24.41 146.45 16% 18.78 140.82 28.16 168.98 HCР-285/28.06.2013. 16.07.2013 16.07.2013 Неактивен 2546
Dabigatran etexilate EU/1/08/442/011 PRADAXA, Capsule, hard, 150, mg, Pack: 60 Boehringer Ingelheim International GmbH, Германия Boehringer Ingelheim Pharma GmbH & Co. KG, Germany 134.95 26.99 161.94 4% 5.4 140.35 28.07 168.42 16% 21.59 161.94 32.39 194.33 КЦ-2710/13.09.2011 27.09.2011 27.09.2011 Неактивен 2546
Dabigatran etexilate EU/1/08/442/006 PRADAXA, Capsule, hard, 110, mg, Pack: 30 Boehringer Ingelheim International GmbH, Германия Boehringer Ingelheim Pharma GmbH & Co. KG, Germany 56 11.2 67.2 4% 2.24 58.24 11.65 69.89 16% 8.96 67.2 13.44 80.64 НСР-7653/01.12.2015. 16.12.2015 16.12.2015 Активен 2545
Dabigatran etexilate EU/1/08/442/002 PRADAXA, Capsule, hard, 75, mg, Pack: 30 Boehringer Ingelheim International GmbH, Германия Boehringer Ingelheim Pharma GmbH & Co. KG, Germany 56 11.2 67.2 4% 2.24 58.24 11.65 69.89 16% 8.96 67.2 13.44 80.64 НСР-7654/01.12.2015. 16.12.2015 16.12.2015 Активен 2543
Showing 6576 to 6601 of 9713 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте